Quick Answer
TransMedics Group, Inc. reported Total Assets of $1.07 billion for the year ending 2025.
- TransMedics Group, Inc. showed an increase of +32.9% in Total Assets from 2024 to 2025.
- This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $38.76 million | Q2 2019: $121.01 million | Q3 2019: $112.62 million | Q1 2020: $96.92 million | Q2 2020: $163.14 million | Q3 2020: $159.32 million | Q1 2021: $145.78 million | Q2 2021: $140.51 million | Q3 2021: $131.15 million | Q1 2022: $124.01 million | Q2 2022: $117.29 million | Q3 2022: $274.87 million | Q1 2023: $287.09 million | Q2 2023: $690.36 million | Q3 2023: $689.23 million | Q1 2024: $723.83 million | Q2 2024: $758.58 million | Q3 2024: $785.57 million | Q1 2025: $837.53 million | Q2 2025: $890.52 million | Q3 2025: $946.03 million.
- Over the full 8 years of available data (2018 to 2025), TransMedics Group, Inc.'s Total Assets has grown by 2,434.3%.
- Historical annual values: Fiscal year 2025: $1.07 billion | Fiscal year 2024: $804.08 million | Fiscal year 2023: $706.05 million | Fiscal year 2022: $277.15 million | Fiscal year 2021: $134.89 million | Fiscal year 2020: $152.03 million | Fiscal year 2019: $105.30 million | Fiscal year 2018: $42.16 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: